Gao et al. reported a case of 66-year-old woman with refractory HS displaying very high PD-L1 expression (more than 90%) who was treated with pembrolizumab combined with gemcitabine, dexamethasone, and cisplatin (GDP) chemotherapy [103]. The gene discussed is CD274; the disease is histiocytic sarcoma.